Cite
MLA Citation
B Polistena et al.. “The societal impact of treatment with natalizumab of relapsing–remitting multiple sclerosis in Italian clinical practice: The Tysabri® PharmacoEconomics (TyPE) Study.” Global & regional health technology assessment, vol. 2019, 2019, p. . http://access.bl.uk/ark:/81055/vdc_100091634779.0x000018